New Delhi, April 14 (IANS) Multinational pharmaceutical giants — with R&D investments and human trials running in China’s Xinjiang region and at Chinese military hospitals — are escaping US regulation that prohibits drug development or clinical testing, according to an article in The Wire, a New York-headquartered global digital magazine.Data put together by The Wire China and WireScreen from ClinicalTrials.gov, a medical trial database maintained by the US National Library of Medicine, …
Trending
- Mareechika (2026) Review: A Psychological Thriller That Weaves Mystery and Emotion Into a Compelling Cinematic Experience
- Krishna Aur Chitthi Review: Arun Govil and Darsheel Safary Deliver a Heartfelt Tale of Faith, Family, and Cricket
- Return Of The Jungle (2026) Movie Review: A Heartwarming Animated Journey Rooted in Indian Storytelling
- Shape of Momo Review: A Breathtaking Portrait of Womanhood, Patriarchy, and Belonging in the Hills of Sikkim
- Rajni Ki Baraat Review (2026): A Bold, Heartwarming Celebration of Female Courage from the Lanes of Darbhanga
- Shree Baba Neeb Karori Maharaj (2026) Movie Review: A Devotional Journey That Touches the Soul
- The Great Grand Superhero Review: Jackie Shroff’s Desi Superhero Saga Is Pure Heart and Chaos
- Ego Raman (2026) Movie Review: A Quiet Psychological Drama That Dares to Go Dark